Dear Sir, I see that you are putting the blame on Judge Du. I would blame it on JT not judge Du. Many of us may have taken an economics class while pursuing our undergraduate and learned about the risk and benefit analysis. With one drug and nothing in pipeline, the best option was to settle with the generics. Amarin should not had gambled that in court. Our market cap right now is 1.3 Billion. We used to be a 10-Billion-dollar company. Had we settled with generics, we would be at least 5 Billion Dollar company now. If anybody is to be blamed, it is the previous management not the court system. After the disaster, I don’t know how BOD got to keep their place. Anyway, it is the past. Hopefully, Marjac prevails in the court. It is truly an achievement that we got this far in the court regardless on winning or losing. Court does see a merit in our case.